Carlsmed, Inc. (CARL)

Carlsmed Statistics

Total Valuation

Carlsmed has a market cap or net worth of $345.82 million. The enterprise value is $332.98 million.

Market Cap	345.82M
Enterprise Value	332.98M

Important Dates

The next confirmed earnings date is Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Carlsmed has 26.58 million shares outstanding.

Current Share Class	26.58M
Shares Outstanding	26.58M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+6.75%
Owned by Insiders (%)	10.98%
Owned by Institutions (%)	1.95%
Float	9.70M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.47
Forward PS	6.30
PB Ratio	13.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.87, with a Debt / Equity ratio of 0.69.

Current Ratio	4.87
Quick Ratio	4.55
Debt / Equity	0.69
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.46

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-56.40%
Revenue Per Employee	$430,000
Profits Per Employee	-$294,427
Employee Count	89
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	13.68
200-Day Moving Average	n/a
Relative Strength Index (RSI)	44.77
Average Volume (20 Days)	69,012

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Carlsmed had revenue of $38.27 million and -$26.20 million in losses. Loss per share was -$6.13.

Revenue	38.27M
Gross Profit	28.33M
Operating Income	-24.70M
Pretax Income	-25.03M
Net Income	-26.20M
EBITDA	-24.52M
EBIT	-24.70M
Loss Per Share	-$6.13

Balance Sheet

The company has $33.47 million in cash and $17.71 million in debt, giving a net cash position of $15.77 million or $0.59 per share.

Cash & Cash Equivalents	33.47M
Total Debt	17.71M
Net Cash	15.77M
Net Cash Per Share	$0.59
Equity (Book Value)	25.66M
Book Value Per Share	-18.04
Working Capital	36.71M

Cash Flow

In the last 12 months, operating cash flow was -$26.98 million and capital expenditures -$523,000, giving a free cash flow of -$27.50 million.

Operating Cash Flow	-26.98M
Capital Expenditures	-523,000
Free Cash Flow	-27.50M
FCF Per Share	-$1.03

Margins

Gross margin is 74.02%, with operating and profit margins of -64.53% and -65.40%.

Gross Margin	74.02%
Operating Margin	-64.53%
Pretax Margin	-65.40%
Profit Margin	-65.40%
EBITDA Margin	-64.08%
EBIT Margin	-64.53%
FCF Margin	n/a

Dividends & Yields

Carlsmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-7.51%
FCF Yield	-7.89%

Analyst Forecast

The average price target for Carlsmed is $18.33, which is 40.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.33
Price Target Difference	40.89%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Carlsmed has an Altman Z-Score of -2.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.18
Piotroski F-Score	n/a